Integrated photonic biosensors: leading the path to point-of-care diagnostics

Presentation by Maarten Buijs, Roadmap and Program Consultant at PhotonDelta.

Rapid and cost-effective diagnostics at the point of care has been pursued for decades, but so far only little progress has been achieved. This became painfully apparent with the outbreak of the Covid-19 pandemic.

No diagnostic platform or biosensor can accommodate the stringent requires of low cost, ease of use, high selectivity and specificity, speed and the capability to detect multiple disease or infection markers simultaneously. With the recent progress in integrated photonics, the development of such a sensor is taking shape. Many projects are underway worldwide to turn these into commercially viable propositions. It is therefore to be expected that biosensors will be one of the major drivers in the growth of integrated photonics as an industry.

PhotonDelta is working on a roadmap for biosensors based on integrated photonics, which will provide the Dutch ecosystem of integrated photonics companies and institutes with the guidance to expand on their leading position in this area. This presentation will provide details of the main content of the roadmap, which will be published in a few months.

About Maarten Buijs
Maarten Buijs has over 20 years of experience in bringing complex technologies to market in leading companies such as Philips, FEI – Thermo Fisher, ASML, Elekta and Moba. He has held responsibility for research, development and engineering for a wide range of leading-edge products and technologies, ranging from corrected electron microscopes, the EUV lithography machine, and brachytherapy equipment for high-dose radiation treatment of cancers to egg sorting. At present he is engaged as the program manager for biosensors at PhotonDelta. He will be speaking at the conference.

About PhotonDelta
PhotonDelta is a growth accelerator for the Dutch integrated photonic sector with the mission to realize a € 1 billion industry in The Netherlands by 2026. To realize this goal, a team of experts actively supports its partners with strategic investments, knowledge and network, resulting in an acceleration of the development and manufacturing of integrated photonics solutions through innovation, reducing time-to-market, and creating economy of scale.

PhotonDelta was initiated in 2016 as an open-innovation project launched by Eindhoven University of Technology, after which it soon expanded its scope to national level, involving companies and public investors in order to form a public-private partnership at the end of 2018. During the relatively short period of its existence, PhotonDelta has established itself as a global authority and one of Europe’s leading innovation hubs with a dedicated investment fund of € 236 million.

Over the past few years, PhotonDelta has invested considerable amounts of capital and energy into organizing and financing the core of the Dutch integrated photonics supply-chain. A number of start-ups have transformed into mature companies, each with their own distinctive technological propositions, setting the foundation of a strong Dutch supply chain that is able to design, manufacture, package and test high quality integrated photonic solutions based on InP as well as TriPleX (SiN) technology, making The Netherlands the obvious choice for companies that are looking to innovate with integrated photonics.

Besides supporting SMEs and enterprises that are looking to innovate their products with integrated photonics, PhotonDelta is also actively involved in the startup scene. Through its Startup Studio programme, which is planned to be launched in Q4 2020 / Q1 2021, PhotonDelta gives startups the opportunity to join its ecosystem and benefit from different services, such as seed and growth capital, access to IP libraries and building blocks, human capital and recruitment services, infrastructure, and more.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.